DESCRIPTION (provided by applicant): This grant is to provide support for the activities of the Eastern Cooperative Oncology Group (ECOG) Chair, Robert L. Comis, M.D.; the senior scientific leadership of the Group; and programs developed by Dr. Comis to enhance the Group's scientific activity and patient accrual. The activities and specific aims supported by this grant are: to provide high quality senior scientific and administrative medical leadership for ECOG programs, and the infrastructure to support that leadership; to expedite the development and conduct of ECOG Studies; and to improve the opportunity for patient participation in ECOG studies.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
ABT-627Access to InformationAcetatesAchievementActivity CyclesAcuteAcute Myelocytic LeukemiaAddendumAddressAdjuvantAdministratorAdoptedAdultAdverse eventAdvertisingAdvisory CommitteesAdvocacyAdvocateAfrican AmericanAgeAge-YearsAgreementAirAmendmentAngiogenesis InhibitorsAntineoplastic AgentsApoptosisAppearanceAppendixApplications GrantsAppointmentAreaAtrasentanAttentionAuthorization documentationAutologousAutologous Bone Marrow TransplantationAwardAwarenessBenefits and RisksBiological ProductsBiologyBirdsBlindedBone MarrowBostonBreastBudgetsBusinessesCD34 geneCSF3 geneCancer BiologyCancer CenterCancer PatientCancer Trials Support UnitCancer and Leukemia Group BCancer cell lineCarcinomaCaringCell LineCellsCertificate of ConfidentialityCertificationCharacteristicsChargeChemopreventionChildren's Oncology GroupChromosome abnormalityChronicClassificationClinicClinicalClinical Cancer CenterClinical OncologyClinical Practice GuidelineClinical ResearchClinical TrialsClinical Trials Cooperative GroupClinical Trials Data Monitoring CommitteesClinical Trials DesignClosureCodeCollaborationsColorectal CancerCommitCommunicationCommunication ProgramsCommunitiesCommunity Clinical Oncology ProgramCommunity NetworksCommunity PhysicianComplexComputer SecurityConceptionsConditionConduct Clinical TrialsConfidentialityConfidentiality of Patient InformationConflict (Psychology)Conflict of InterestConsciousConsentConsent FormsConstitutionContractsControlled StudyCooperative Research and Development AgreementCorrelative StudyCounselingCountryCuesCyclosporinsCytarabineDailyDalteparinDataData ReportingData SourcesData Storage and RetrievalDatabasesDecision MakingDelawareDenileukin DiftitoxDevelopmentDevelopmental Therapeutics ProgramDexamethasoneDexamethasone/Doxorubicin/PSC 833/VincristineDiagnosisDiagnostic Neoplasm StagingDiarrheaDisclosureDiseaseDisease remissionDisseminated Malignant NeoplasmDocetaxel/DoxorubicinDocetaxel/EstramustineDocetaxel/IrinotecanDoctor of MedicineDoctor of PharmacyDoctor of PhilosophyDocumentationDoseDouble-Blind MethodDrug ApprovalDrug IndustryDrug usageEPO906 (Epothilone B-Novartis)Early DiagnosisEastern Cooperative Oncology GroupEducationEducational MaterialsEducational workshopEffectivenessElderlyElectronic MailElectronicsEmployee StrikesEmploymentEndometrial adenocarcinomaEndometriumEnrollmentEnsureEquilibriumEstramustineEstrogensEthicsEthnic OriginEuropeanEventFaceFacultyFederal GovernmentFellowshipFemaleFilgrastimFire - disastersFloridaFluorouracilFocus GroupsFood, Drug and Cosmetic ActFornet brand of tetrazepamFosteringFoundationsFruitFulvestrantFundingFunding OpportunitiesFutureGemtuzumab OzogamicinGenderGeneticGlioblastomaGoalsGovernmentGovernment regulationsGrantGray unit of radiation doseGroomingGroup MeetingsGroup StructureGrowthGuidelinesHandHead and Neck Squamous Cell CarcinomaHealthHealth FairsHealth Insurance Portability and Accountability ActHealth PlanningHealth StatusHealth educationHematologyHormone ReceptorHormonesHospitalsHumanHuman ResourcesHuman Subject ResearchHydrocortisone/KetoconazoleImatinibImmunoblastic LymphadenopathyImmunologicsIncidenceIndividualIndustryInformation DistributionInformed ConsentInjection of therapeutic agentInstitutesInstitutionInsurance CoverageIntellectual PropertyInterferonsInterleukin-11InternetInterphaseIntravenousInvestigational DrugsJob DescriptionJointsJournalsKnowledgeLabelLaboratoriesLaboratory ResearchLabyrinthLanguageLawyersLeadershipLegalLengthLicensingLifeLinkLiteratureLocal Area NetworksLogisticsLoperamideLymphoblastic LeukemiaMYB geneMaintenanceMalignant NeoplasmsMalignant neoplasm of prostateManufacturer NameMarimastatMarketingMeasuresMediationMedicalMedical centerMedicareMedicineMethodsMinorityMissionModalityModelingMolecularMonitorMonitoring Clinical TrialsMotexafin GadoliniumMovementMucoepidermoid CarcinomaMultiple MyelomaMyeloid LeukemiaNational Cancer InstituteNational Cancer Institute of Canada Clinical Trials GroupNational Surgical Adjuvant Breast and Bowel ProjectNatureNegative Axillary Lymph NodeNeoplasm MetastasisNew AgentsNew EnglandNewly DiagnosedNewsletterNucleotidesOccupational activity of managing financesOctreotideOctreotide Acetate SaltOffice for Human Research ProtectionsOperative Surgical ProceduresOprelvekinOutcomeOxidation-ReductionPamphletsPaperParticipantPathologyPathway interactionsPatient EducationPatient ParticipationPatient RepresentativePatientsPeer ReviewPemetrexedPemetrexed DisodiumPennsylvaniaPeptidesPerformancePersonsPharmaceutical PreparationsPharmacogeneticsPharmacogenomicsPharmacologic SubstancePharmacologyPhasePhase II Clinical TrialsPhase III Clinical TrialsPhiladelphiaPhilosophyPhysiciansPilot ProjectsPlacebosPlayPoliciesPopulationPositioning AttributePostmenopausePreparationPress ReleasesPreventionPrimary Care PhysicianPrincipal InvestigatorPrintingProceduresProcessProduct LabelingProductionProgesteroneProgram EvaluationProteinase-Activated ReceptorsProteomicsProto-Oncogene Proteins c-mybProtocols documentationPublic HealthPublic RelationsPublicationsPuerto RicoPurposeQualifyingQuality of lifeRaceRandomizedRandomized Clinical TrialsRandomized Controlled Clinical TrialsRangeRateRecombinantsRecommendationRecording of previous eventsRecordsRecurrenceRefractoryRegistered nurseRegulationRegulatory AffairsRelapseRelative (related person)Replacement TherapyReportingResearchResearch DesignResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportResistanceResolutionResource AllocationResourcesRightsRiskRisk FactorsRoleRouteSDZ-PSC-833SafetyScheduleScienceScientistScreening procedureSecureSeleniumServicesSignal TransductionSignal Transduction InhibitionSiteSlideSodiumSolutionsSouth AfricaSouth AmericaSpeedStable DiseaseStaff DevelopmentStagingStandards of Weights and MeasuresState GovernmentStatutes and LawsStem cellsSteroidsStrategic PlanningStructureSuggestionSupplementationSupport GroupsSupport SystemSurveysSystemT-Cell LymphomaTamoxifenTechnologyTelephoneTelevisionThalidomideTherapeuticTherapeutic AgentsTherapeutics CommitteeThinkingTimeTitleTo specifyTodayTouch sensationToxic effectTrainingTraining and EducationTranslational ResearchTransplantationUSA GeorgiaUnderrepresented MinorityUnderserved PopulationUnited StatesUnited States Dept. of Health and Human ServicesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUnited States Public Health ServiceUniversitiesUpdateVisionVotingWeekWestern Asia GeorgiaWisconsinWomanWorkWritingYeastsZD1839 (IRESSA)abstractingadvocacy organizationsanastrozoleanti-cancer therapeuticauthoritybasecancer carecancer preventioncancer therapychemotherapeutic agentchemotherapyclinically relevantcollegecomputerized data processingconceptcoralcostcytotoxicdata acquisitiondata managementdaydesigndesiredocetaxeldocument outlinesdosagedrug discoverydrug distributiondrug marketexperiencefallsfarnesyltranstransferasefollow-upfrontiergemcitabinegene therapyglucose transportgranulocytehealth care deliveryhormone therapyhuman subjecthydroxyureaimprovedinnovationinterestkidney celllectureslung small cell carcinomamacrophagemalemalignant breast neoplasmmalignant stomach neoplasmmembernewsnovelolder patientoncologyoutcome forecastpatient advocacy grouppatient orientedpaymentperformance sitepre-clinicalpressurepreventprogramsprospectiveprospectusesprotein farnesyltransferaseprotocol developmentresearch studyresponsesargramostimsoundstatistical centerstemsubcutaneoussuccesssymposiumsymptom managementtooltrial comparingtumoruser-friendlyvolunteerward
No Sub Projects information available for 5U10CA086802-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U10CA086802-09
Patents
No Patents information available for 5U10CA086802-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U10CA086802-09
Clinical Studies
No Clinical Studies information available for 5U10CA086802-09
News and More
Related News Releases
No news release information available for 5U10CA086802-09
History
No Historical information available for 5U10CA086802-09
Similar Projects
No Similar Projects information available for 5U10CA086802-09